This is a 60-minute CFPC Mainpro+ certified eCME program for Canadian HCPs. The goal is to provide education on the burden of respiratory syncytial virus (RSV) and guidance on RSV prevention and control measures. This program is designed to provide practical information on the monoclonal antibodies authorized for RSV prophylaxis in Canada, including a new long-acting monoclonal antibody for all infants.
This program has received an unrestricted educational grant or in-kind support from Sanofi.